DB17918ExperimentalProtein Based Therapies
TOL2 is a modified form of the acetylcholine receptor being investigated for the treatment of myasthenia gravis.
- Also known as
- TOL 2 · TOL-2
What you can answer from here — as of March 06, 2025
Which companies are running trials of TOL2, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account